Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RAPH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ACOT13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNASEL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GBAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LMNA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF451 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPCD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MALAT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NOTCH2NL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PALLD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HINT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UCHL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MARK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NPLOC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANXA2P2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPL31 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DAP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on